1 March 2014 in Biochemical and Biophysical Research Communications
25 August 2023 in Molecular Psychiatry
Genomic imprinting disorders are caused by the disruption of genomic imprinting processes leading to a deficit or increase of an active allele. Their unique molecular mechanisms underlying imprinted genes offer an opportunity to investigate epigenetic-based therapy for reactivation of an inactive allele or reduction of an active allele. Current treatments are based on managing symptoms, not targeting the molecular mechanisms underlying imprinting disorders. Here, we highlight molecular approaches of therapeutic candidates in preclinical and clinical studies for individual imprinting disorders. These include the significant progress of discovery and testing of small molecules, antisense oligonucleotides, and CRISPR mediated genome editing approaches as new therapeutic strategies. We discuss the significant challenges of translating these promising therapies from the preclinical stage to the clinic, especially for genome editing based approaches.
3 July 2025 in Nature Communications
Prader-Willi Syndrome (PWS) is caused by the loss of expression of paternally expressed genes in the human 15q11.2-q13 imprinting domain. A set of imprinted genes that are active on the paternal but silenced on the maternal chromosome are intricately regulated by a bipartite imprinting center (PWS-IC) located in the PWS imprinting domain. We previously discovered that euchromatic histone lysine N-methyltransferase-2 (EHMT2/G9a) inhibitors are capable of un-silencing PWS-associated genes by restoring their expression from the maternal chromosome. Here, in mice lacking the Ehmt2 gene, we document un-silencing of the imprinted Snrpn/Snhg14 gene on the maternal chromosome in the late embryonic and postnatal brain. Using PWS and Angelman syndrome patient derived cells with either paternal or maternal deletion of 15q11.2-q13, we have found that chromatin of maternal PWS-IC is closed and has compact 3D folding confirmation. We further show that a distinct noncoding RNA (TSS4-280118) preferentially transcribed from the upstream of the PWS-IC of maternal chromosome interacts with EHMT2 and forms a heterochromatin complex in CIS on the maternal chromosome. Inactivation of TSS4-280118 by CRISPR/Cas9 editing results in unsilencing of the expression of SNRPN and SNORD116 from the maternal chromosome. Taken together, these findings demonstrate that allele-specific recruitment of EHMT2 is required to maintain the maternal imprints. Our findings provide mechanistic insights and support a model for imprinting maintenance of the PWS imprinted domain.
14 November 2025 in Communications Biology
Social behavior deficits are a hallmark of autism and other neuropsychiatric disorders. SHANK3, a common causal gene for autism, is highly expressed in the nucleus accumbens (NAc), a critical brain region for social behaviors. We previously characterized conventional Shank3Δe4-22 deletion mice with increased unilateral social investigation and hypoactive NAc circuits. Here, we describe a new exon 4-22 floxed (Shank3flox/flox) mouse line that we developed to test the hypothesis that SHANK3 in the NAc is necessary for social behaviors. We find that knockdown of Shank3 in the NAc of male and female mice decreases social preference in the 3-chamber assay and decreases social motivation in the social conditioned place preference assay. Shank3 NAc deficiency does not alter food reward seeking, reciprocal social investigation, or anxiety-like behaviors, which we report in conventional Shank3Δe4-22 deletion mice. These data elucidate a specific mechanism of Shank3 in the NAc on social behavior and social motivation.
25 March 2026 in Molecular Psychiatry
Behavioral regression occurs in approximately 40% of individuals with SHANK3-associated autism spectrum disorder (ASD). We previously reported that significant behavioral regression in a small cohort of patients with SHANK3 haploinsufficiency, triggered by subclinical infections, responded to immunomodulator treatments. We hypothesize that behavioral regression results from the interplay between SHANK3 deficiency and neuroinflammation. Using Shank3 exon 4–22 deletion heterozygous mutant (Sh3+/−) mouse, which shows no significant behavior impairments, we established a preclinical model – Shank3 haploinsufficiency mouse undergoing a systemic inflammation challenge via intraperitoneal injection of lipopolysaccharides (LPS). We found that, two weeks after LPS challenge, wild-type mice (WT) recovered but Sh3+/− mice exhibited motor impairment, anxiety-like behaviors, and excessive grooming, similar to Shank3 exon 4–22 deletion homozygous mutants. Anti-inflammatory treatment partially reversed LPS-induced behavioral changes. Transcriptomic analysis revealed upregulation of neuroinflammation-related genes and downregulation of synaptic function-related genes in LPS challenged Sh3+/− mice. Especially, pro-inflammatory genes and microglia markers were overly activated that may result from the increased toll-like receptor 4 (TLR4) in Sh3+/− mice. Microglia overactivation elevated synapse engulfment and disrupted synaptic protein may underlie LPS-triggered worsen behavior phenotypes in Sh3+/− mice. Together, our findings indicate that neuroinflammation increases the penetrance of behavioral impairment in Shank3 haploinsufficiency mice and support a potential mechanism for the behavioral regression in human SHANK3 related disorders for future investigations.
10 January 2025 in bioRxiv
Deficits in social interaction are a hallmark symptom of autism and other neuropsychiatric disorders. SHANK3 encodes a postsynaptic density scaffold protein and is one of the most common causal genes for autism. SHANK3 protein is highly expressed in the nucleus accumbens (NAc), a critical brain region underlying motivated behavior, including social motivation. We previously reported that global
Shank3
Δe
4–22 deletion mice have decreased motivation for palatable food, increased unilateral social investigation, and show a hypoactive NAc and NAc-connected circuits. We thus developed a new
Shank3
flox/flox
mouse tool to conditionally knockdown SHANK3 in a region-specific manner. We found that knockdown of Shank3 in the NAc decreased social preference in the 3-chamber assay and decreased social motivation in the social conditioned place preference (sCPP) assay. Shank3- NAc deletion did not alter food reward seeking, reciprocal social investigation, or anxiety-like behaviors, that we report in global
Shank3
Δe
4–22 deletion mice. These data establish a novel and specific role of Shank3 in the NAc on social motivation.